Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.
AIMay 30, 2024Antitumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA.
AIMay 30, 2024BEIJING,May 24,2024-- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE:EDU and SEHK: 9901),a provider of private educational services in C
AIMay 30, 2024SHENZHEN,China,May 24,2024--This is a report fromXinhua Silk Road: The dance drama Wing Chun stole the show at the 20th China (Shenzhen) International Cultural Industries Fair,held in Shenzhen,asserti
AIMay 30, 2024DHAKA,Bangladesh,May 24,2024-- Within just three years of its inception,Nagad,a leading mobile financial service provider based in Bangladesh,has established itself as the most successful startup uni
AIMay 30, 2024
English Morning News: Your Source for Regional News and Corporate
© English Morning News
Privacy Policy